Viewing Study NCT06604858


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-05 @ 6:07 PM
Study NCT ID: NCT06604858
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2024-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
Sponsor: MedSIR
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module